MXPA04001402A - Compuestos de imidazopiridina novedosos con efecto terapeutico. - Google Patents

Compuestos de imidazopiridina novedosos con efecto terapeutico.

Info

Publication number
MXPA04001402A
MXPA04001402A MXPA04001402A MXPA04001402A MXPA04001402A MX PA04001402 A MXPA04001402 A MX PA04001402A MX PA04001402 A MXPA04001402 A MX PA04001402A MX PA04001402 A MXPA04001402 A MX PA04001402A MX PA04001402 A MXPA04001402 A MX PA04001402A
Authority
MX
Mexico
Prior art keywords
therapeutic effect
imidazopyridine compounds
novel imidazopyridine
novel
compounds
Prior art date
Application number
MXPA04001402A
Other languages
English (en)
Inventor
Starke Ingemar
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MXPA04001402A publication Critical patent/MXPA04001402A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a derivados de imidazopiridina de la formula (I) que inhiben la secrecion gastrica exogenamente o endogenamente estimulada y por lo tanto se pueden usar en la prevencion y tratamiento de enfermedades inflamatorias gastrointestinales.
MXPA04001402A 2001-08-22 2002-08-21 Compuestos de imidazopiridina novedosos con efecto terapeutico. MXPA04001402A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102808A SE0102808D0 (sv) 2001-08-22 2001-08-22 New compounds
PCT/SE2002/001489 WO2003018582A1 (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect

Publications (1)

Publication Number Publication Date
MXPA04001402A true MXPA04001402A (es) 2004-05-27

Family

ID=20285105

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001402A MXPA04001402A (es) 2001-08-22 2002-08-21 Compuestos de imidazopiridina novedosos con efecto terapeutico.

Country Status (19)

Country Link
US (1) US20040220209A1 (es)
EP (1) EP1421083A1 (es)
JP (1) JP2005501870A (es)
KR (1) KR20040036723A (es)
CN (1) CN100343252C (es)
AR (1) AR035465A1 (es)
BR (1) BR0211846A (es)
CA (1) CA2456350A1 (es)
HU (1) HUP0401350A3 (es)
IL (1) IL160143A0 (es)
IS (1) IS7159A (es)
MX (1) MXPA04001402A (es)
NO (1) NO20040760L (es)
NZ (1) NZ531110A (es)
PL (1) PL367971A1 (es)
RU (1) RU2294935C2 (es)
SE (1) SE0102808D0 (es)
WO (1) WO2003018582A1 (es)
ZA (1) ZA200401114B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
WO2005070927A2 (en) * 2004-01-26 2005-08-04 Altana Pharma Ag 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
EA011512B1 (ru) * 2004-12-17 2009-04-28 Ракуалиа Фарма Инк. Производные хромана, полезные в качестве антагонистов кислотной помпы
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
CA2645007A1 (en) * 2006-03-17 2007-09-27 Raqualia Pharma Inc. Chromane derivatives
WO2008059373A1 (es) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Vacuna contra la malaria, basada en la subunidad 200l de la proteína msp1 de plasmodium vivax.
KR200449743Y1 (ko) * 2008-03-11 2010-08-05 주식회사 보루네오가구 파티션용 상부 스크린의 고정구조
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
JP5802898B2 (ja) 2009-07-09 2015-11-04 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
PT2480546E (pt) * 2009-09-24 2015-02-09 Hoffmann La Roche Derivados de imidazopiridina ou imidazopirimidina como inibidores de fosfodisterase 10a
FR2962437B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
JP6373280B2 (ja) * 2013-01-31 2018-08-15 ネオメド・インスティチュート イミダゾピリジン化合物及びその使用
CA2909477A1 (en) * 2013-04-30 2014-11-06 F. Hoffmann-La Roche Ag Pd-catalyzed coupling of pyrazole amides
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
KR20040036723A (ko) 2004-04-30
US20040220209A1 (en) 2004-11-04
HUP0401350A3 (en) 2009-03-02
IL160143A0 (en) 2004-06-20
CN1543464A (zh) 2004-11-03
EP1421083A1 (en) 2004-05-26
IS7159A (is) 2004-02-20
WO2003018582A1 (en) 2003-03-06
HUP0401350A2 (hu) 2004-12-28
AR035465A1 (es) 2004-05-26
NZ531110A (en) 2005-10-28
PL367971A1 (en) 2005-03-07
NO20040760L (no) 2004-02-20
CN100343252C (zh) 2007-10-17
RU2294935C2 (ru) 2007-03-10
BR0211846A (pt) 2004-09-08
SE0102808D0 (sv) 2001-08-22
ZA200401114B (en) 2005-06-22
RU2004103628A (ru) 2005-06-27
CA2456350A1 (en) 2003-03-06
JP2005501870A (ja) 2005-01-20

Similar Documents

Publication Publication Date Title
MY121389A (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
SE9700661D0 (sv) New compounds
TW515798B (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
MXPA04001402A (es) Compuestos de imidazopiridina novedosos con efecto terapeutico.
SE9401197D0 (sv) Active compounds
MY121387A (en) Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
SE9802794D0 (sv) New compounds
MX2011005769A (es) Derivados de imidazopiridina que inhiben la secrecion del acido gastrico.
MY119012A (en) New compounds
ATE381568T1 (de) Pyrano(2,3-c)imidazo(1,2-a)pyridin-derivate zur behandlung von gastrointestinalen erkrankungen
MY140718A (en) Novel imidazopyridine compound ii with therapeutic effect
TW200508234A (en) Novel imidazopyridine compound I with therapeutic effect
TW200505866A (en) Novel imidazopyridine compound iii with therapeutic effect
ES2150494T3 (es) Derivados sustituidos de quinolina y su utilizacion como inhibidores de la secrecion de acido gastrico.
AR044854A1 (es) Compuesto de imidazopiridina
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.